Clinical Trial Update: Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating adjuvant FOLFOX after total mesorectal excision for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• FOLFOX

Snippet

Sponsor: Yonsei University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN